Boston Scientific (BSX) Other Non-Current Liabilities (2009 - 2026)

Boston Scientific has disclosed Other Non-Current Liabilities across 18 years of filings, most recently posting $2.5 billion for Q2 2026.

• In Q2 2026, Other Non-Current Liabilities rose 4.07% year-over-year to $2.5 billion; the TTM figure through Jun 2026 stood at $2.5 billion (up 4.07% YoY), while the FY2025 annual figure was $2.4 billion, up 28.61% from the prior year.
• Other Non-Current Liabilities came in at $2.5 billion for Q2 2026 at Boston Scientific, roughly flat from $2.5 billion in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $2.5 billion in Q2 2026 to a low of $1.8 billion in Q2 2024.
• Average Other Non-Current Liabilities over 5 years is $2.1 billion, with a median of $2.0 billion recorded in 2022.
• Year-over-year, Other Non-Current Liabilities dropped 16.55% in 2022 and jumped 32.39% in 2025.
• Over 5 years, Other Non-Current Liabilities stood at $2.0 billion in 2022, then slipped by 3.34% to $2.0 billion in 2023, then fell by 4.93% to $1.9 billion in 2024, then gained by 28.61% to $2.4 billion in 2025, then increased by 3.12% to $2.5 billion in 2026.
• Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $2.5 billion in Q2 2026, $2.5 billion in Q1 2026, and $2.4 billion in Q4 2025.